Authors:
KOTTS CE
SU FM
LEDDY C
DODD T
SCATES S
SHALABY MR
WIRTH CM
GILTINAN D
SCHROFF RW
FRITZBERG AR
SHEPARD HM
SLAMON DJ
HUTCHINS BM
Citation: Ce. Kotts et al., (186)RE-LABELED ANTIBODIES TO P185(HER2) AS HER2-TARGETED RADIOIMMUNOPHARMACEUTICAL AGENTS - COMPARISON OF PHYSICAL AND BIOLOGICAL CHARACTERISTICS WITH I-125 AND I-131-LABELED COUNTERPARTS, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 11(2), 1996, pp. 133-144
Authors:
CARRASQUILLO JA
REYNOLDS JC
BUNN PA
FOON KA
SHUKE N
SCHROFF RW
MULSHINE JL
PERENTESIS P
SZYMENDERA J
HOROWITZ M
LARSON SM
Citation: Ja. Carrasquillo et al., PHARMACOKINETICS OF IN-111 T101 (ANTI-CD5) MONOCLONAL-ANTIBODY IN PATIENTS WITH CUTANEOUS T-CELL LYMPHOMA, Antibody immunoconjugates, and radiopharmaceuticals, 6(2), 1993, pp. 111-126